Cabaletta Bio (CABA) Profit After Tax (2018 - 2025)

Cabaletta Bio's Profit After Tax history runs 8 years deep, the most recent figure standing at -$41.9 million for Q4 2025.

• On a quarterly basis, Profit After Tax fell 28.63% year-over-year to -$41.9 million in Q4 2025; TTM through Dec 2025 was -$167.9 million, a 44.91% decrease from a year earlier, with the FY2025 full-year figure at -$167.8 million, down 44.8% from the prior year.
• Profit After Tax grew to -$41.9 million in Q4 2025 per CABA's latest filing, from -$44.9 million in the prior quarter.
• Across five years, Profit After Tax topped out at -$9.7 million in Q1 2021 and bottomed at -$45.1 million in Q2 2025.
• The 5-year median for Profit After Tax is -$16.2 million (2023), against an average of -$22.5 million.
• Across the five-year window, Profit After Tax advanced 1.16% in 2022 and tumbled 90.53% in 2024, its largest moves.
• Year by year, Profit After Tax stood at -$13.9 million in 2021, then fell by 13.38% to -$15.7 million in 2022, then sank by 32.02% to -$20.8 million in 2023, then plunged by 56.83% to -$32.6 million in 2024, then declined by 28.63% to -$41.9 million in 2025.
• Per Business Quant, the three latest CABA Profit After Tax figures stand at -$41.9 million (Q4 2025), -$44.9 million (Q3 2025), and -$45.1 million (Q2 2025).